BRWA
AMED

B. Riley Wealth Advisors’s Amedisys AMED Stock Holding History

B. Riley Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,446
Closed -$648K – 1371
2021
Q1 		$648K Sell
2,446
-1,029
-30% -$290K 0.02% 615
2020
Q4 		$1.02M Buy
3,475
+1,054
+44% +$270K 0.05% 321
2020
Q3 		$573K Buy
2,421
+647
+36% +$147K 0.03% 482
2020
Q2 		$353K Sell
1,774
-739
-29% -$138K 0.02% 574
2020
Q1 		$462K Buy
2,513
+72
+3% +$12.8K 0.04% 411
2019
Q4 		$408K Sell
2,441
-72
-3% -$10.7K 0.03% 497
2019
Q3 		$330K Buy
2,513
+854
+51% +$111K 0.03% 551
2019
Q2 		$202K Sell
1,659
-47
-3% -$5.58K 0.02% 716
2019
Q1 		$211K Buy
+1,706
New +$214K 0.03% 637

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

B. Riley Wealth Advisors's AMED Position: Q2 2021 in Review

B. Riley Wealth Advisors sold out of Amedisys (AMED) in Q2 2021, closing a stake of 2,446 shares — an estimated $648K sold.

B. Riley Wealth Advisors first reported a position in AMED in Q1 2019 and held it in 9 quarters. The position peaked at $1.02M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • B. Riley Wealth Advisors reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 2,446 Amedisys shares in Q2 2021, an estimated $648K.
  • B. Riley Wealth Advisors first reported a position in Amedisys in Q1 2019 and held it in 9 quarters.
  • B. Riley Wealth Advisors's Amedisys position peaked at $1.02M in Q4 2020.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.